All Posts By

Ed

Workplace Drug Use Will Affect The Safety Of Everyone

Media Release 28 July 2020
The Say Nope To Dope campaign says that despite the sales pitch from the Drug Foundation that employers are overreacting and Andrew Little claiming that cannabis use is already ‘widely available’, employers have every reason to be concerned about attempts to legalise the recreational use of cannabis.

In the US, marijuana legalisation has had serious ramifications for businesses. Increased marijuana availability and use has increased the number of employees testing positive for marijuana in the workforce.

Marijuana is the most commonly detected substance and has the highest drug positivity rate among all other tested substances across the majority of industry sectors in the U.S. (Quest Diagnostics, 2017). Among the top-ranking industries for the highest rates of positive marijuana testing, transportation and warehousing was number one with 33.3%. Meanwhile the construction industry had an average of 26.7% positive marijuana testing (Quest Diagnostics, 2018).

“Contrary to the Drug Foundation’s claims about Canada where legalisation has been only recent and good research not readily available on trends, in the three-year period following legalisation in Colorado and Washington, positive oral-fluid test results for marijuana use increased almost 75%, from 5.1% to 8.9%. Marijuana urine test results in Washington and Colorado are now double the national average,” says spokesperson Aaron Ironside.

One in four marijuana users who are employed admit to getting high at work within the past year, according to a new survey of cannabis consumers in Washington, Oregon and Colorado, three states where recreational weed is legal. Workforce marijuana-positivity rates in all “legal” states but one (Alaska) are above the national average. For example, 2018 positivity rates in Maine (5.0%), Oregon (4.3%), Nevada (4.0%), Massachusetts (3.3%), Colorado (3.0%), California (2.5%), and Washington (2.4%) are higher than the national average (2.3%) (Quest Diagnostics, 2019). Most states that have legalised marijuana show an increasing trend in positivity rates.

Insurance claims have become a growing concern among companies in US states that have legalised marijuana because if marijuana use is allowed or drug testing ignored, employers are at risk of liability claims when a marijuana-related injury or illness occurs onsite. Studies consistently show marijuana users have significantly lower levels of commitment to their work than non-users, and are absent more often. Even when controlling for alcohol use, pot users are 106% more likely to have missed at least one day of work in the last month because they “just didn’t want to be there.”

Ironically, on the NZ Drug Foundation’s website, their fact sheet on driving while high says “For regular smokers, the news is worse. A new study shows that chronic, heavy users of cannabis are not, as one might think, less impaired due to higher tolerance but in fact may be constantly impaired – even for some weeks after ceasing altogether.” (our emphasis added)

Where there is more accessibility there will be an increase in use, whatever substance that is. When something is legal it is the ‘green’ light to use it with no consequences. This is why workplace drug testing acts as a deterrent from this unsafe behaviour.”

Comprehensive medicinal cannabis bill drawn – Shane Reti

Media Release National Party Dr Shane Reti 23 July 2020
My Member’s Bill to implement a comprehensive medicinal cannabis regime that would widen access to medicinal cannabis and license high quality domestic production, has been drawn in Parliament, MP for Whangarei Shane Reti says.

“New Zealanders deserve greater access to high quality medicinal cannabis products to ease their suffering, but we must have the right regulatory and legislative controls in place.

“My bill is a more comprehensive alternative to the Government’s cannabis bill. The Government has said it will increase access now and leave it to officials to think through the controls and the consequences later. That’s typical of this Government but it’s not acceptable.

“The Government declined the bill 18 months ago, if they hadn’t New Zealanders would have access to affordable medicinal cannabis right now.

The Misuse of Drugs (Medicinal Cannabis) Amendment Bill (No 2) will achieve the following:

Medicinal cannabis products will be approved in the same way a medicine is approved by Medsafe. No loose leaf cannabis products will be approved.

Medical practitioners will decide who should have access to a Medicinal Cannabis Card, which will certify them to buy medicinal cannabis products.

Medicinal cannabis products will be pharmacist-only medicine.

Cultivators and manufacturers must be licenced for commercial production. Licence holders and staff will be vetted to ensure they are fit and proper persons.

A licensing regime that will create a safe market for medicinal cannabis products. Cultivators and manufacturers will not be able to be located within 5km of residential land, or 1km of sensitive sites such as schools and wahi tapu.

No advertising of medicinal cannabis products to the public will be permitted.

The Ministry of Health will review the legislation in five years.

“National is determined to be a constructive opposition working on new ideas and new policies. This bill is the result of significant work, including a study I conducted overseas and reflects a blend of international best practice, tailored to New Zealand.

“I recognise there is a delayed medicinal cannabis process underway by the Government, but I encourage them to pick up the enormous amount of work done by National in Opposition and implement our comprehensive reforms to ensure this is done once and done right. So that New Zealanders in need can access high quality medicinal cannabis products to ease their suffering.”
http://www.voxy.co.nz/health/5/369707

Deafening Silence on Bill Which Improves Access To Medicinal Marijuana

Media Release 27 July 2020
The Say Nope To Dope campaign says that the deafening silence on the drawing out of the ballot of Dr Shane Reti’s medicinal cannabis private members bill which improves access for patients shows the true agenda of the Yes campaigners for primarily the recreational legalisation of cannabis.

“Drug advocates like the Greens, the Drug Foundation and Helen Clark have used medicinal cannabis as justification for legalising cannabis – yet when a bill is drawn which could further help achieve their goal, their silence is deafening,” says spokesperson Aaron Ironside.

“This is evidence that their campaign is fraudulent. The problem that they have is that if they supported this bill, it would undermine their ultimate goal of legalising cannabis for recreational use. But medicinal cannabis is their smokescreen for misleading the public on the real desire for promoting a yes vote for legalisation.”

“We’re calling on the Yes campaign to drop the façade of their desire to help patients. Their focus is purely on the right of people to use drugs for recreational reasons.”

We support further quality research into the components of the marijuana plant for delivery via non-smoked forms, with products established as safe, effective and approved and listed by the Ministry of Health to be prescribed via their doctor – with appropriate funding and pricing for patients. Neurologists, palliative care and pain specialists should have a key role in this process.

“Ultimately, the medical profession should be dictating the direction of the medicinal cannabis debate, not marijuana advocates with a hidden agenda.”

Cannabis referendum: Why the construction industry is worried weed will be legalised

NewsHub 24 July 2020
Our additional comment: “We’ve got a limited pool of people already, potentially going to be more limited. [It] might encourage people to use drugs more, become more dependent on drugs.”
A survey of almost 200 civil contracting companies found more than 66 percent worry that legalising cannabis will negatively affect them.
#votenopetodope

Some construction companies warn they’ll face a shortage of workers if cannabis is legalised in the referendum.

The high-risk industry will continue to test its workers even if it is legal, and worries that will rule out a large group of employees.

Drug testing on construction sites is common practice.

“It’s a zero-tolerance policy, we test pre-employment, we test on incidence and we test randomly,” said David Howard, Managing Director of Construction Contracts Ltd.

Howard worries it will make it even tougher to find workers.

“We’ve got a limited pool of people already, potentially going to be more limited,” he told Newshub. “[It] might encourage people to use drugs more, become more dependent on drugs.”

A survey of almost 200 civil contracting companies found more than 66 percent worry that legalising cannabis will negatively affect them.
READ MORE: https://www.newshub.co.nz/home/politics/2020/07/cannabis-referendum-why-the-construction-industry-is-worried-weed-will-be-legalised.html

facebook_icon

Mike’s Minute: Government being dishonest over cannabis vote

NewsTalk ZB 20 July 2020
Our additional comment: [The pamphlet] reads “the bill’s purpose is to reduce harm to people and communities.” No, it isn’t. The bill’s purpose is to legalise, or not, something that is currently illegal. You are voting yes or no, legal or illegal, nothing more. Could an outworking of the vote mean there might be less harm to people and communities? Possibly. Or indeed possibly not. Because that’s the case, you can’t make the claim something will happen, if in fact it might not. That’s fraudulent.

So the con continues to unfold from the government over the cannabis vote in September.

In my holiday mail was the official pamphlet, direct from the politburo. Putin would have been proud of it.

Remember the official line is that the government holds no view on this, this is our choice, and they’re staying out of it. If you still believe that you’ve been asleep or you’re not that bright.

When it was claimed Family First was getting money from an American lobby group, Andrew Little blew his lid. It was completely unjustifiable for a foreign group to involve themselves in a local debate and vote. But there was, of course, no money at all.

And yet this is the same Minister who has overseen a series of rules that allow people like the Drug Foundation to raise whatever they like from whoever they like and not have to tell anyone who those people are, and he is just fine with it.

Back to the pamphlet, it reads “the bill’s purpose is to reduce harm to people and communities.” No, it isn’t. The bill’s purpose is to legalise, or not, something that is currently illegal. You are voting yes or no, legal or illegal, nothing more.

Could an outworking of the vote mean there might be less harm to people and communities? Possibly. Or indeed possibly not. Because that’s the case, you can’t make the claim something will happen, if in fact it might not. That’s fraudulent.

The pamphlet ends with the question, “where can I get more information?” The answer, of course, is the internet. But they offer you one tiny piece of the internet, namely their own website. Can we conclude that if that particular piece of the net they’re sprooking is as gerrymandered and biased as the pamphlet, then the only information you’ll be getting is the stuff they want you to see?
READ MORE: https://www.newstalkzb.co.nz/on-air/mike-hosking-breakfast/video/mikes-minute-government-being-dishonest-over-cannabis-vote/

facebook_icon

Marijuana companies could target South Auckland – Simeon Brown

Te Ao Maori News 16 July 2020
Our additional comment: “Where are they going to set up their shops?” Simeon Brown says. “I used to live in South Auckland. The big alcohol companies like to have more shops there than in other parts of Auckland.” The Pakuranga MP fears the marijuana companies will follow suit.
Yes – of course they will, just as they have overseas
See the evidence here https://saynopetodope.org.nz/social-justice/

National MP Simeon Brown fears for South Auckland if recreational weed becomes legal.

“Where are they going to set up their shops?” Simeon Brown says.

“I used to live in South Auckland. The big alcohol companies like to have more shops there than in other parts of Auckland.”

The Pakuranga MP fears the marijuana companies will follow suit.

Simeon Brown has long opposed Green MP Chloe Swarbrick’s crusade to legalise recreational weed. He’s happy that medical weed is legal but wants it left at that.

If recreational weed is legalised under the proposed bill, MP Brown says the businesses will market marijuana to young people.

“We’re also going to see it promoted. Big business will be getting involved,” MP Brown says.

“They will be targeting people to start earlier and use it for longer.”

Brown notes that drugs have already been decriminalised. Police have greater flexibility to avoid drug convictions.
READ MORE: https://www.teaomaori.news/marijuana-companies-could-target-south-auckland-simeon-brown
twitter follow us

UK hospitals treat 125,000 cannabis users over the past five years

Daily Mail 14 July 2020
Our additional comment: The number of cannabis-related hospitalisations per year in England has leapt by more than 50 per cent since 2013 – from 19,765 to 31,130. The dramatic rise has coincided with an increasingly liberal approach to policing the Class B drug in many parts of the country. In Durham, police now turn a blind eye to possession – and even small-scale cultivation.

The devastating effect of cannabis on Britain’s mental health can be revealed for the first time today.

As campaigners call for the drug’s legalisation, shocking figures obtained by The Mail on Sunday show that it has caused more than 125,000 hospital admissions in the last five years.

And around 15,000 of those cases involved teenagers – some of whom were rushed to A&E departments suffering serious psychosis.

Analysis carried out by NHS officials for this paper has also revealed how children below the age of ten have been admitted to hospital after taking the powerful and addictive substance. Some people hooked on the drug have taken their own lives after suffering hallucinations and many more are now unable to lead normal lives, according to doctors.

The number of cannabis-related hospitalisations per year in England has leapt by more than 50 per cent since 2013 – from 19,765 to 31,130.

The dramatic rise has coincided with an increasingly liberal approach to policing the Class B drug in many parts of the country. In Durham, police now turn a blind eye to possession – and even small-scale cultivation. Last week, the Royal College of Psychiatrists announced it was setting up a panel to consider backing legalisation of cannabis – arguing that could be a way to control its increasing strength.
READ MORE: https://www.dailymail.co.uk/news/article-6273159/UK-hospitals-treat-125-000-cannabis-users-past-five-years.html

facebook_icon

Will Jones III: Legalizing Marijuana isn’t about Social Justice

Poppot.org 4 October 2019
Our additional comment: Calls to legalize marijuana often lead with the cry of social justice. Many advocates argue that legalization will right the wrongs of our racist past in the criminal justice system. In reality, legalization would make our society much less just than it is now. Legalization would lead to increased commercialization of marijuana, playing into the hands of an intoxicating, addictive, for-profit industry that is appropriating problems of systemic injustice to the tune of billions of dollars in profits.

Calls to legalize marijuana often lead with the cry of social justice. Many advocates argue that legalization will right the wrongs of our racist past in the criminal justice system.

In reality, legalization would make our society much less just than it is now. Legalization would lead to increased commercialization of marijuana, playing into the hands of an intoxicating, addictive, for-profit industry that is appropriating problems of systemic injustice to the tune of billions of dollars in profits. Pennsylvania should instead focus on decriminalization.

Marijuana commercialization advocates have shrewdly pointed to ethnically disparate arrest rates that show African-Americans are disproportionately targeted for enforcement of marijuana laws. While the problems they highlight are painfully true, their solution is both ineffective and disingenuous. It does nothing to punish, prosecute, or remove individuals or institutions with records of racism and discriminatory law enforcement practices – true reform. Instead, it creates a predatory industry that targets communities of color and other disadvantaged communities with an over saturation of ads and stores likes its predecessors Big Tobacco, the alcohol industry, and the lottery.

When I walk out the front door of my home the first store that I get to in any direction is a liquor store. Going a bit further, when I get to a convenience store, it is so plastered with advertisements for liquor, cigarettes, and the lottery that I can’t even see inside the windows.

A study from Johns Hopkins University found that, “such stores have been shown to be an important component of the social infrastructure that destabilizes communities.” We shouldn’t be celebrating legislation that permits irresponsible, predatory industries marketing another intoxicating and addictive substance to embed itself in our communities.

As they anticipate and push for federal legalization, major alcohol brands including HeinekenMolson CoorsBlue Moon, and Corona have already invested billions in the marijuana industry. And to quote marijuana investors, “this is only the beginning.”

Big Tobacco isn’t standing by either. In 2018, Altria, the parent company to Phillip Morris, invested over a billion dollars in marijuana and subsequently invested another several billion in Juul, the vaping company that is now being investigated by the FDA for their marketing practices that have created a near epidemic of teen vaping. The CDC has now linked marijuana vapes to a majority of over 800 cases of a mysterious lung ailment and at least two of twelve subsequent deaths.
READ MORE: https://poppot.org/2019/10/04/legalizing-marijuana-isnt-about-social-justice/

Diverse Group of Top Researchers and Scientists Send Joe Biden Letter Commending Pro-Science Stance on Marijuana Policy

Media Release SAM-US 15 July 2020
Our additional comment: “..the researchers point out that the marijuana industry, which profits off the promotion and sale of high potency candies, concentrates, and vapes, has taken advantage of vulnerable communities, using Denver as an example — which has an average of one marijuana storefront for every 43 residents of color in minority neighborhoods. On this, the researchers conclude that “communities historically impacted by biased policing through marijuana enforcement must be built up through targeted criminal justice reform, not billionaire-backed pot shops.”

Today, a broad, diverse group of renowned scientists, led by the first Black United States Magistrate Judge and researchers from Johns Hopkins and Harvard Medical School, sent a letter to former Vice President and current presumptive Democratic nominee, Joe Biden, commending him for his unwavering commitment to a well-reasoned approach to marijuana policy.

The researchers, members of the Science Advisory Board for Smart Approaches to Marijuana (SAM) — the largest, national, non-partisan policy group dedicated to offering science-based alternatives to marijuana commercialization — have vast experience in the fields of science, medicine, and addiction that drive them to promote science in the discussion on marijuana policy.

“Science, not politics, must guide our drug policy decisions,” said Dr. Kevin Sabet, president of SAM and a former three-time White House drug policy advisor. “Marijuana commercialization would only financially benefit a handful of wealthy investors and saddle disadvantaged communities in our country with further addiction.”

The letter, sent just days after the Biden-Sanders Taskforce did not put marijuana legalization into the presumptive Democratic nominee’s campaign platform, outlines the preponderance of data supporting Vice President Biden’s contention that marijuana is a harmful substance.

Furthermore, the researchers point out that the marijuana industry, which profits off the promotion and sale of high potency candies, concentrates, and vapes, has taken advantage of vulnerable communities, using Denver as an example — which has an average of one marijuana storefront for every 43 residents of color in minority neighborhoods. On this, the researchers conclude that “communities historically impacted by biased policing through marijuana enforcement must be built up through targeted criminal justice reform, not billionaire-backed pot shops.”

In closing, the researchers stated that they “applaud and appreciate your science-based approach that is equally cognizant of legitimate concerns regarding social justice and marijuana-policing. We hope you will continue to uphold these important standards and thank you for your steadfast commitment to public health.”

The letter is signed by the following individuals:

Judge Arthur L. Burnett, Sr.
First Black United States Magistrate Judge
Executive Director, National African American Drug Policy Coalition

Hoover Adger, Jr, M.D., M.P.H.
Director, Adolescent Medicine
Professor of Pediatrics
Johns Hopkins University School of Medicine

Eden Evins, M.D., M.P.H.
Cox Family Professor of Psychiatry, Harvard Medical School
Founding Director, Mass General Hospital Center for Addiction Medicine

Sion Kim Harris, Ph.D., C.P.H.
Co-Director, Center for Adolescent Behavioral Health Research
Division of Adolescent/Young Adult Medicine, Boston Children’s Hospital
Associate Professor, Department of Pediatrics, Harvard Medical School

Jodi Gilman, Ph.D.
Associate Professor, Harvard Medical School

Christian Thurstone, M.D.
Associate Professor of Psychiatry, University of Colorado, Denver

Kimber P. Richter, Ph.D., M.P.H.
Professor and Director, UKanQuit
KUMed Hospital Tobacco Treatment Service

Aaron Weiner, Ph.D.
ABPP Licensed Clinical Psychologist

Yifrah Kaminer, M.D., M.B.A.
Professor of Psychiatry, University of Connecticut School of Medicine
Professor of Pediatrics, Connecticut Children’s Medical Center’s Injury Prevention Center

Marilyn A. Huestis, Ph.D.
Institute for Emerging Health Professions
Thomas Jefferson University

Christine Miller, Ph.D.
Former Research Associate
Johns Hopkins School of Medicine

 

Official pamphlet on cannabis referendum accused of making subjective claims

NewsTalk ZB 13 July 2020
Our additional comment: “People have started to receive pamphlets in the mail regarding the election, including on the cannabis legislation referendum. The pamphlet has been criticised the ‘Say Nope to Dope’ campaign, which has sought legal advice about some of the wording used. The line in question reads “the bill’s purpose is to reduce harm to people and communities” – something they say is a highly subjective statement.”
And Chloe Swarbrick tries (unsuccessfully) to defend the indefensible…

Official information on the cannabis referendum has sparked a backlash from some quarters.

People have started to receive pamphlets in the mail regarding the election, including on the cannabis legislation referendum.

The pamphlet has been criticised the ‘Say Nope to Dope’ campaign, which has sought legal advice about some of the wording used.

The line in question reads “the bill’s purpose is to reduce harm to people and communities” – something they say is a highly subjective statement.

However, Chloe Swarbrick, the Green Party’s drug reform spokesperson, told Heather du Plessis-Allan that is the purpose of the proposed law.

“The bill’s title is Cannabis Legislation and Control, and the purpose, as outlined in the draft bill, is to implement control to increase wellbeing and decrease harm from cannabis in our communities.”

She says that the wording was approved and worked on by all parties in Parliament.
https://www.newstalkzb.co.nz/on-air/heather-du-plessis-allan-drive/audio/chloe-swarbrick-on-whether-the-cannabis-referendum-information-is-subjective/

signup-rollKeep up with family issues in NZ.
Receive our weekly emails direct to your Inbox.